|
![]() |
|
|
|
|
» Apply for a Grant
- FAQs - Young Investigator - Independent Investigator - Distinguished Investigator - Staglin Award » Grantee List - Young Investigators - Independent Investigators - Distinguished Investigators - Staglin Awards
» Prizes
- Lieber Prize - Falcone Prize - Ruane Prize - Goldman-Rakic Prize - Freedman Award - Klerman Award » For Grantees - Young Investigator Fact Sheet - Independent Investigator Fact Sheet - Distinguished Investigator Fact Sheet - Staglin Award Fact Sheet
|
Lynn L. Johnson, Pharm. D. (Young Investigator 2005) of the University of Colorado Health Sciences Center, proposes studying the impact of marijuana use on schizophrenics, 25 percent of whom abuse the substance. Although some suggest that people with schizophrenia may use marijuana to self medicate against hallucinations, delusions and the depression and anxiety from these symptoms, it is unknown if the substance makes users feel better or worse. Marijuana intoxication in non-schizophrenics generally causes decreased recall of words and may decrease reaction time and inhibitions. Additionally, marijuana may cause distractibility as demonstrated by difficulty in subjects keeping their eyes on a moving target and in other tasks. However, marijuana may have different effects in schizophrenia. Cannabis (marijuana) receptors are concentrated in the brain and cannabinoid system maladjustment may be associated with the difficulty in thinking found in schizophrenia. The proposed research project aims to study if clinical symptoms, learning, memory, inhibition and distractibility are improved or made worse by the acute ingestion of tetrahydrocannabinol (THC), the active ingredient in marijuana. Program Area: SCHIZOPHRENIA/PSYCHOTIC DISORDERS\Schizophrenia\Substance Abuse |
Announcements
NARSAD Award Winners
Latest News from NARSAD
|